Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report

BACKGROUND: Gemcitabine and cisplatin are chemotherapeutic agents used for treating multiple cancers, and these agents are sometimes used in combination. Drug-induced thrombotic microangiopathy (TMA) is a rare but potentially fatal complication. It typically presents as a systemic disease with the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikubo, Masashi, Shimomura, Yoshimitsu, Hiramoto, Nobuhiro, Sawamura, Naohiko, Yamaguchi, Takako, Hara, Shigeo, Ishikawa, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114690/
https://www.ncbi.nlm.nih.gov/pubmed/33980166
http://dx.doi.org/10.1186/s12882-021-02386-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114690/
https://www.ncbi.nlm.nih.gov/pubmed/33980166
http://dx.doi.org/10.1186/s12882-021-02386-y

Ejemplares similares